1-4 of 4
Gregory W. Albers
Close
Sort by
Journal Articles

Association of Bleeding Severity with Mortality with Extended Thromboprophylaxis in the Medically Ill in the Mariner Trial

Alex C. Spyropoulos, MD, Walter Ageno, Gregory W. Albers, MD, C. Gregory Elliott, MD, Jonathan L. Halperin, MD, William R. Hiatt, Gregory Maynard, MD, P. Gabriel Steg, MD, Jeffrey I. Weitz, MD, Theodore E. Spiro, MD, Wentao Lu, PhD, Chiara Sugarmann, BSN, MSHS, Concetta Lipardi, MD PhD, Gary E. Raskob, PhD, Elliot S. Barnathan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3669.
https://doi.org/10.1182/blood-2019-122621
Published: 2019
Journal Articles

Is Differential Activity of Enoxaparin and Unfractionated Heparin According to the Location of Deep-Vein Thrombosis in Acute Ischemic Stroke Patients Driven by Different Pathogenic Mechanisms?.

Ludovic Drouet, David G. Sherman, Gregory W. Albers, Christopher Bladin, Cesare Fieschi, Alberto A. Gabbai, Carlos S. Kase, William O’Riordan, Graham F. Pineo
Journal: Blood
Blood (2007) 110 (11): 303.
https://doi.org/10.1182/blood.V110.11.303.303
Published: 2007
Journal Articles

Prevention of Venous Thromboembolism after Acute Ischemic Stroke with Enoxaparin Versus Unfractionated Heparin and the Impact of Stroke Severity.

David G. Sherman, MD, Gregory W. Albers, MD, Christopher Bladin, MD, Min Chen, MS, Cesare Fieschi, MD, Alberto A. Gabbai, MD, Carlos S. Kase, MD, William O’Riordan, MD, Graham F. Pineo, MD, for the PREVAIL Investigators
Journal: Blood
Blood (2006) 108 (11): 713.
https://doi.org/10.1182/blood.V108.11.713.713
Published: 2006
Journal Articles

Outcomes for Ximelagatran Compared with Warfarin According to INR Control: Results from SPORTIF III and V Atrial Fibrillation Trials.

Scott Kaatz, DO, FACP, Harvey D. White, Michael Gruber, Gregory W. Albers
Journal: Blood
Blood (2005) 106 (11): 902.
https://doi.org/10.1182/blood.V106.11.902.902
Published: 2005